Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Moon

Showing results (941-950 of 975) with videos related to

Pageof 98
Sort By:
European Heart Journal. Cardiovascular Imaging|June 23, 2026
Indications, protocols, and interpretation of cardiovascular imaging for the evaluation and management of athletes. A Clinical Consensus Statement of the European Association of Preventive Cardiology (EAPC) and the European Association of Cardiovascular Imaging (EACVI) of the European Society of Cardiology (ESC). Part 2-Cardiovascular Magnetic Resonance, Cardiac CT and Nuclear ImagingViviana Maestrini, Sabiha Gati, Flavio D'Ascenzi, et al.
Molecular Genetics and Metabolism|March 1, 2021
Standardising clinical outcomes measures for adult clinical trials in Fabry disease: A global Delphi consensusD Moreno-Martinez, P Aguiar, C Auray-Blais, et al.
Circulation. Heart Failure|May 9, 2025
Proteomic Analysis of Valsartan for Attenuating Disease Evolution in Early Sarcomeric Hypertrophic Cardiomyopathy (VANISH) Clinical TrialConstantin-Cristian Topriceanu, Christoffer Rasmus Vissing, Anna Axelsson Raja, et al.
Clinical Epigenetics|July 16, 2020
H3K27ac acetylome signatures reveal the epigenomic reorganization in remodeled non-failing human heartsJiayi Pei, Magdalena Harakalova, Thomas A Treibel, et al.
Journal of the American College of Cardiology|January 8, 2025
Demographic-Based Personalized Left Ventricular Hypertrophy Thresholds for Hypertrophic Cardiomyopathy DiagnosisHunain Shiwani, Rhodri H Davies, Constantin-Cristian Topriceanu, et al.
Journal of the American College of Cardiology|July 8, 2026
Natural History of Asymptomatic Phenotypically Mild HCM: Insights From the SHaRe RegistryConstantin-Cristian Topriceanu, Iswaree Devi Balakrishnan, Christoffer Rasmus Vissing, et al.
European Heart Journal|July 15, 2026
Trientine for hypertrophic cardiomyopathy: a phase 2 trialJohn P Farrant, Susanna Dodd, Anna Rosala-Hallas, et al.
Circulation|January 27, 2023
Myocardial Involvement After Hospitalization for COVID-19 Complicated by Troponin Elevation: A Prospective, Multicenter, Observational StudyJessica Artico, Hunain Shiwani, James C Moon, et al.
BJU International|December 12, 2024
The impact of post-nephroureterectomy surgically induced chronic kidney disease on survival outcomesDhruv Puri, Margaret F Meagher, Zhenjie Wu, et al.
Cell Host & Microbe|October 24, 2021
Prior infection with SARS-CoV-2 boosts and broadens Ad26.COV2.S immunogenicity in a variant-dependent mannerRoanne Keeton, Simone I Richardson, Thandeka Moyo-Gwete, et al.
Pageof 98

Showing results (941-950 of 975) with videos related to

Sort By:
Pageof 98
European Heart Journal. Cardiovascular Imaging|June 23, 2026
Indications, protocols, and interpretation of cardiovascular imaging for the evaluation and management of athletes. A Clinical Consensus Statement of the European Association of Preventive Cardiology (EAPC) and the European Association of Cardiovascular Imaging (EACVI) of the European Society of Cardiology (ESC). Part 2-Cardiovascular Magnetic Resonance, Cardiac CT and Nuclear ImagingViviana Maestrini, Sabiha Gati, Flavio D'Ascenzi, et al.
Molecular Genetics and Metabolism|March 1, 2021
Standardising clinical outcomes measures for adult clinical trials in Fabry disease: A global Delphi consensusD Moreno-Martinez, P Aguiar, C Auray-Blais, et al.
Circulation. Heart Failure|May 9, 2025
Proteomic Analysis of Valsartan for Attenuating Disease Evolution in Early Sarcomeric Hypertrophic Cardiomyopathy (VANISH) Clinical TrialConstantin-Cristian Topriceanu, Christoffer Rasmus Vissing, Anna Axelsson Raja, et al.
Clinical Epigenetics|July 16, 2020
H3K27ac acetylome signatures reveal the epigenomic reorganization in remodeled non-failing human heartsJiayi Pei, Magdalena Harakalova, Thomas A Treibel, et al.
Journal of the American College of Cardiology|January 8, 2025
Demographic-Based Personalized Left Ventricular Hypertrophy Thresholds for Hypertrophic Cardiomyopathy DiagnosisHunain Shiwani, Rhodri H Davies, Constantin-Cristian Topriceanu, et al.
Journal of the American College of Cardiology|July 8, 2026
Natural History of Asymptomatic Phenotypically Mild HCM: Insights From the SHaRe RegistryConstantin-Cristian Topriceanu, Iswaree Devi Balakrishnan, Christoffer Rasmus Vissing, et al.
European Heart Journal|July 15, 2026
Trientine for hypertrophic cardiomyopathy: a phase 2 trialJohn P Farrant, Susanna Dodd, Anna Rosala-Hallas, et al.
Circulation|January 27, 2023
Myocardial Involvement After Hospitalization for COVID-19 Complicated by Troponin Elevation: A Prospective, Multicenter, Observational StudyJessica Artico, Hunain Shiwani, James C Moon, et al.
BJU International|December 12, 2024
The impact of post-nephroureterectomy surgically induced chronic kidney disease on survival outcomesDhruv Puri, Margaret F Meagher, Zhenjie Wu, et al.
Cell Host & Microbe|October 24, 2021
Prior infection with SARS-CoV-2 boosts and broadens Ad26.COV2.S immunogenicity in a variant-dependent mannerRoanne Keeton, Simone I Richardson, Thandeka Moyo-Gwete, et al.
Pageof 98